The global market for Opioid Induced Constipation (OIC) Drug was valued at US$ 2775 million in the year 2024 and is projected to reach a revised size of US$ 3785 million by 2031, growing at a CAGR of 4.6% during the forecast period.

Opioid Induced Constipation (OIC) Drug Market

Although opioids are very effective for treating and managing pain, their use frequently results in opioid-induced constipation (OIC). Treatment options for OIC may be as simple as changing diet or as complicated as requiring several medicines and laxatives.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Opioid Induced Constipation (OIC) Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Opioid Induced Constipation (OIC) Drug.

The Opioid Induced Constipation (OIC) Drug market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Opioid Induced Constipation (OIC) Drug market comprehensively. Regional market sizes, concerning products by Type, by Distribution Channel, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Opioid Induced Constipation (OIC) Drug manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Distribution Channel, and by regions.

Scope of Opioid Induced Constipation (OIC) Drug Market Report

Report Metric	Details
Report Name	Opioid Induced Constipation (OIC) Drug Market
Accounted market size in year	US$ 2775 million
Forecasted market size in 2031	US$ 3785 million
CAGR	4.6%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Lubiprostone Methyl Naltrexone Bromide Naldemedine Alvimopan Other
Segment by Distribution Channel	Hospital Pharmacies Retail Pharmacies Online Pharmacies
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Ironwood Pharmaceuticals, Daiichi Sankyo Co, Pfizer, Progenics Pharmaceuticals, Shionogi &, Allergan, Nektar Therapeutics, Purdue Pharma, S.L.A. Pharma, Mundipharma International Limited, Ono Pharmaceutical, Takeda Pharmaceutical Company Limited, Theravance Biopharma, Bausch Health, Cosmo Pharmaceuticals SA, Daewoong Pharmaceutical, C.B. Fleet Company, Sucampo Pharmaceuticals
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Opioid Induced Constipation (OIC) Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Opioid Induced Constipation (OIC) Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Distribution Channel, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Opioid Induced Constipation (OIC) Drug Market growing?

Ans: The Opioid Induced Constipation (OIC) Drug Market witnessing a CAGR of 4.6% during the forecast period 2025-2031.

What is the Opioid Induced Constipation (OIC) Drug Market size in 2031?

Ans: The Opioid Induced Constipation (OIC) Drug Market size in 2031 will be US$ 3785 million.

Who are the main players in the Opioid Induced Constipation (OIC) Drug Market report?

Ans: The main players in the Opioid Induced Constipation (OIC) Drug Market are Ironwood Pharmaceuticals, Daiichi Sankyo Co, Pfizer, Progenics Pharmaceuticals, Shionogi &, Allergan, Nektar Therapeutics, Purdue Pharma, S.L.A. Pharma, Mundipharma International Limited, Ono Pharmaceutical, Takeda Pharmaceutical Company Limited, Theravance Biopharma, Bausch Health, Cosmo Pharmaceuticals SA, Daewoong Pharmaceutical, C.B. Fleet Company, Sucampo Pharmaceuticals

What are the Type segmentation covered in the Opioid Induced Constipation (OIC) Drug Market report?

Ans: The Types covered in the Opioid Induced Constipation (OIC) Drug Market report are Lubiprostone, Methyl Naltrexone Bromide, Naldemedine, Alvimopan, Other

1 Opioid Induced Constipation (OIC) Drug Market Overview

1.1 Product Definition

1.2 Opioid Induced Constipation (OIC) Drug by Type

1.2.1 Global Opioid Induced Constipation (OIC) Drug Market Value Comparison by Type (2024 VS 2031)

1.2.2 Lubiprostone

1.2.3 Methyl Naltrexone Bromide

1.2.4 Naldemedine

1.2.5 Alvimopan

1.2.6 Other

1.3 Opioid Induced Constipation (OIC) Drug by Distribution Channel

1.3.1 Global Opioid Induced Constipation (OIC) Drug Market Value by Distribution Channel (2024 VS 2031)

1.3.2 Hospital Pharmacies

1.3.3 Retail Pharmacies

1.3.4 Online Pharmacies

1.4 Global Opioid Induced Constipation (OIC) Drug Market Size Estimates and Forecasts

1.4.1 Global Opioid Induced Constipation (OIC) Drug Revenue 2020-2031

1.4.2 Global Opioid Induced Constipation (OIC) Drug Sales 2020-2031

1.4.3 Global Opioid Induced Constipation (OIC) Drug Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Opioid Induced Constipation (OIC) Drug Market Competition by Manufacturers

2.1 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers (2020-2025)

2.2 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Opioid Induced Constipation (OIC) Drug Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Opioid Induced Constipation (OIC) Drug, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Opioid Induced Constipation (OIC) Drug, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Opioid Induced Constipation (OIC) Drug, Product Type & Application

2.7 Global Key Manufacturers of Opioid Induced Constipation (OIC) Drug, Date of Enter into This Industry

2.8 Global Opioid Induced Constipation (OIC) Drug Market Competitive Situation and Trends

2.8.1 Global Opioid Induced Constipation (OIC) Drug Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Opioid Induced Constipation (OIC) Drug Players Market Share by Revenue

2.8.3 Global Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Opioid Induced Constipation (OIC) Drug Market Scenario by Region

3.1 Global Opioid Induced Constipation (OIC) Drug Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Opioid Induced Constipation (OIC) Drug Sales by Region: 2020-2031

3.2.1 Global Opioid Induced Constipation (OIC) Drug Sales by Region: 2020-2025

3.2.2 Global Opioid Induced Constipation (OIC) Drug Sales by Region: 2026-2031

3.3 Global Opioid Induced Constipation (OIC) Drug Revenue by Region: 2020-2031

3.3.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Region: 2020-2025

3.3.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Region: 2026-2031

3.4 North America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Country

3.4.1 North America Opioid Induced Constipation (OIC) Drug Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2031)

3.4.3 North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2031)

3.4.4 U.S.

3.4.5 Canada

3.5 Europe Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Country

3.5.1 Europe Opioid Induced Constipation (OIC) Drug Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2031)

3.5.3 Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Region

3.6.1 Asia Pacific Opioid Induced Constipation (OIC) Drug Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2031)

3.6.3 Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.6.13 Philippines

3.7 Latin America Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Country

3.7.1 Latin America Opioid Induced Constipation (OIC) Drug Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2031)

3.7.3 Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Facts & Figures by Country

3.8.1 Middle East and Africa Opioid Induced Constipation (OIC) Drug Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2031)

3.8.3 Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 U.A.E

4 Segment by Type

4.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2031)

4.1.1 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2020-2025)

4.1.2 Global Opioid Induced Constipation (OIC) Drug Sales by Type (2026-2031)

4.1.3 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2031)

4.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2020-2031)

4.2.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2020-2025)

4.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Type (2026-2031)

4.2.3 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2020-2031)

4.3 Global Opioid Induced Constipation (OIC) Drug Price by Type (2020-2031)

5 Segment by Distribution Channel

5.1 Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2031)

5.1.1 Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2020-2025)

5.1.2 Global Opioid Induced Constipation (OIC) Drug Sales by Distribution Channel (2026-2031)

5.1.3 Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2020-2031)

5.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2020-2031)

5.2.1 Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2020-2025)

5.2.2 Global Opioid Induced Constipation (OIC) Drug Revenue by Distribution Channel (2026-2031)

5.2.3 Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2020-2031)

5.3 Global Opioid Induced Constipation (OIC) Drug Price by Distribution Channel (2020-2031)

6 Key Companies Profiled

6.1 Ironwood Pharmaceuticals

6.1.1 Ironwood Pharmaceuticals Company Information

6.1.2 Ironwood Pharmaceuticals Description and Business Overview

6.1.3 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolio

6.1.5 Ironwood Pharmaceuticals Recent Developments/Updates

6.2 Daiichi Sankyo Co

6.2.1 Daiichi Sankyo Co Company Information

6.2.2 Daiichi Sankyo Co Description and Business Overview

6.2.3 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product Portfolio

6.2.5 Daiichi Sankyo Co Recent Developments/Updates

6.3 Pfizer

6.3.1 Pfizer Company Information

6.3.2 Pfizer Description and Business Overview

6.3.3 Pfizer Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Pfizer Opioid Induced Constipation (OIC) Drug Product Portfolio

6.3.5 Pfizer Recent Developments/Updates

6.4 Progenics Pharmaceuticals

6.4.1 Progenics Pharmaceuticals Company Information

6.4.2 Progenics Pharmaceuticals Description and Business Overview

6.4.3 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolio

6.4.5 Progenics Pharmaceuticals Recent Developments/Updates

6.5 Shionogi &

6.5.1 Shionogi & Company Information

6.5.2 Shionogi & Description and Business Overview

6.5.3 Shionogi & Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.5.4 Shionogi & Opioid Induced Constipation (OIC) Drug Product Portfolio

6.5.5 Shionogi & Recent Developments/Updates

6.6 Allergan

6.6.1 Allergan Company Information

6.6.2 Allergan Description and Business Overview

6.6.3 Allergan Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Allergan Opioid Induced Constipation (OIC) Drug Product Portfolio

6.6.5 Allergan Recent Developments/Updates

6.7 Nektar Therapeutics

6.7.1 Nektar Therapeutics Company Information

6.7.2 Nektar Therapeutics Description and Business Overview

6.7.3 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product Portfolio

6.7.5 Nektar Therapeutics Recent Developments/Updates

6.8 Purdue Pharma

6.8.1 Purdue Pharma Company Information

6.8.2 Purdue Pharma Description and Business Overview

6.8.3 Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Purdue Pharma Opioid Induced Constipation (OIC) Drug Product Portfolio

6.8.5 Purdue Pharma Recent Developments/Updates

6.9 S.L.A. Pharma

6.9.1 S.L.A. Pharma Company Information

6.9.2 S.L.A. Pharma Description and Business Overview

6.9.3 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.9.4 S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product Portfolio

6.9.5 S.L.A. Pharma Recent Developments/Updates

6.10 Mundipharma International Limited

6.10.1 Mundipharma International Limited Company Information

6.10.2 Mundipharma International Limited Description and Business Overview

6.10.3 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.10.4 Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product Portfolio

6.10.5 Mundipharma International Limited Recent Developments/Updates

6.11 Ono Pharmaceutical

6.11.1 Ono Pharmaceutical Company Information

6.11.2 Ono Pharmaceutical Description and Business Overview

6.11.3 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.11.4 Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolio

6.11.5 Ono Pharmaceutical Recent Developments/Updates

6.12 Takeda Pharmaceutical Company Limited

6.12.1 Takeda Pharmaceutical Company Limited Company Information

6.12.2 Takeda Pharmaceutical Company Limited Description and Business Overview

6.12.3 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product Portfolio

6.12.5 Takeda Pharmaceutical Company Limited Recent Developments/Updates

6.13 Theravance Biopharma

6.13.1 Theravance Biopharma Company Information

6.13.2 Theravance Biopharma Description and Business Overview

6.13.3 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product Portfolio

6.13.5 Theravance Biopharma Recent Developments/Updates

6.14 Bausch Health

6.14.1 Bausch Health Company Information

6.14.2 Bausch Health Description and Business Overview

6.14.3 Bausch Health Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Bausch Health Opioid Induced Constipation (OIC) Drug Product Portfolio

6.14.5 Bausch Health Recent Developments/Updates

6.15 Cosmo Pharmaceuticals SA

6.15.1 Cosmo Pharmaceuticals SA Company Information

6.15.2 Cosmo Pharmaceuticals SA Description and Business Overview

6.15.3 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.15.4 Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product Portfolio

6.15.5 Cosmo Pharmaceuticals SA Recent Developments/Updates

6.16 Daewoong Pharmaceutical

6.16.1 Daewoong Pharmaceutical Company Information

6.16.2 Daewoong Pharmaceutical Description and Business Overview

6.16.3 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.16.4 Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product Portfolio

6.16.5 Daewoong Pharmaceutical Recent Developments/Updates

6.17 C.B. Fleet Company

6.17.1 C.B. Fleet Company Company Information

6.17.2 C.B. Fleet Company Description and Business Overview

6.17.3 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.17.4 C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product Portfolio

6.17.5 C.B. Fleet Company Recent Developments/Updates

6.18 Sucampo Pharmaceuticals

6.18.1 Sucampo Pharmaceuticals Company Information

6.18.2 Sucampo Pharmaceuticals Description and Business Overview

6.18.3 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales, Revenue and Gross Margin (2020-2025)

6.18.4 Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product Portfolio

6.18.5 Sucampo Pharmaceuticals Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Opioid Induced Constipation (OIC) Drug Industry Chain Analysis

7.2 Opioid Induced Constipation (OIC) Drug Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Opioid Induced Constipation (OIC) Drug Production Mode & Process Analysis

7.4 Opioid Induced Constipation (OIC) Drug Sales and Marketing

7.4.1 Opioid Induced Constipation (OIC) Drug Sales Channels

7.4.2 Opioid Induced Constipation (OIC) Drug Distributors

7.5 Opioid Induced Constipation (OIC) Drug Customer Analysis

8 Opioid Induced Constipation (OIC) Drug Market Dynamics

8.1 Opioid Induced Constipation (OIC) Drug Industry Trends

8.2 Opioid Induced Constipation (OIC) Drug Market Drivers

8.3 Opioid Induced Constipation (OIC) Drug Market Challenges

8.4 Opioid Induced Constipation (OIC) Drug Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Ironwood Pharmaceuticals

Daiichi Sankyo Co

Pfizer Inc

Progenics Pharmaceuticals

Mundipharma International Limited

Ono Pharmaceutical

Takeda Pharmaceutical Company Limited

Theravance Biopharma

Bausch Health

Cosmo Pharmaceuticals SA

Daewoong Pharmaceutical

C. B. Fleet Company

Sucampo Pharmaceuticals

List of Tables

Table 1. Global Opioid Induced Constipation (OIC) Drug Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Opioid Induced Constipation (OIC) Drug Market Value by Distribution Channel (2024 VS 2031) & (US$ Million)

Table 3. Global Opioid Induced Constipation (OIC) Drug Market Competitive Situation by Manufacturers in 2024

Table 4. Global Opioid Induced Constipation (OIC) Drug Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Opioid Induced Constipation (OIC) Drug Average Price (USD/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Opioid Induced Constipation (OIC) Drug, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Opioid Induced Constipation (OIC) Drug, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Opioid Induced Constipation (OIC) Drug, Product Type & Application

Table 12. Global Key Manufacturers of Opioid Induced Constipation (OIC) Drug, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Opioid Induced Constipation (OIC) Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Opioid Induced Constipation (OIC) Drug as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2025) & (K Units)

Table 18. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2020-2025)

Table 19. Global Opioid Induced Constipation (OIC) Drug Sales by Region (2026-2031) & (K Units)

Table 20. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2026-2031)

Table 21. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2020-2025)

Table 23. Global Opioid Induced Constipation (OIC) Drug Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2026-2031)

Table 25. North America Opioid Induced Constipation (OIC) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K Units)

Table 27. North America Opioid Induced Constipation (OIC) Drug Sales by Country (2026-2031) & (K Units)

Table 28. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Opioid Induced Constipation (OIC) Drug Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K Units)

Table 32. Europe Opioid Induced Constipation (OIC) Drug Sales by Country (2026-2031) & (K Units)

Table 33. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Opioid Induced Constipation (OIC) Drug Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Opioid Induced Constipation (OIC) Drug Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Opioid Induced Constipation (OIC) Drug Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Opioid Induced Constipation (OIC) Drug Sales (K Units) by Type (2020-2025)

Table 51. Global Opioid Induced Constipation (OIC) Drug Sales (K Units) by Type (2026-2031)

Table 52. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2020-2025)

Table 53. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Type (2026-2031)

Table 54. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2020-2025)

Table 57. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Type (2026-2031)

Table 58. Global Opioid Induced Constipation (OIC) Drug Price (USD/Unit) by Type (2020-2025)

Table 59. Global Opioid Induced Constipation (OIC) Drug Price (USD/Unit) by Type (2026-2031)

Table 60. Global Opioid Induced Constipation (OIC) Drug Sales (K Units) by Distribution Channel (2020-2025)

Table 61. Global Opioid Induced Constipation (OIC) Drug Sales (K Units) by Distribution Channel (2026-2031)

Table 62. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2020-2025)

Table 63. Global Opioid Induced Constipation (OIC) Drug Sales Market Share by Distribution Channel (2026-2031)

Table 64. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million) by Distribution Channel (2020-2025)

Table 65. Global Opioid Induced Constipation (OIC) Drug Revenue (US$ Million) by Distribution Channel (2026-2031)

Table 66. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2020-2025)

Table 67. Global Opioid Induced Constipation (OIC) Drug Revenue Market Share by Distribution Channel (2026-2031)

Table 68. Global Opioid Induced Constipation (OIC) Drug Price (USD/Unit) by Distribution Channel (2020-2025)

Table 69. Global Opioid Induced Constipation (OIC) Drug Price (USD/Unit) by Distribution Channel (2026-2031)

Table 70. Ironwood Pharmaceuticals Company Information

Table 71. Ironwood Pharmaceuticals Description and Business Overview

Table 72. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 73. Ironwood Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product

Table 74. Ironwood Pharmaceuticals Recent Developments/Updates

Table 75. Daiichi Sankyo Co Company Information

Table 76. Daiichi Sankyo Co Description and Business Overview

Table 77. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 78. Daiichi Sankyo Co Opioid Induced Constipation (OIC) Drug Product

Table 79. Daiichi Sankyo Co Recent Developments/Updates

Table 80. Pfizer Company Information

Table 81. Pfizer Description and Business Overview

Table 82. Pfizer Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 83. Pfizer Opioid Induced Constipation (OIC) Drug Product

Table 84. Pfizer Recent Developments/Updates

Table 85. Progenics Pharmaceuticals Company Information

Table 86. Progenics Pharmaceuticals Description and Business Overview

Table 87. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 88. Progenics Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product

Table 89. Progenics Pharmaceuticals Recent Developments/Updates

Table 90. Shionogi & Company Information

Table 91. Shionogi & Description and Business Overview

Table 92. Shionogi & Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 93. Shionogi & Opioid Induced Constipation (OIC) Drug Product

Table 94. Shionogi & Recent Developments/Updates

Table 95. Allergan Company Information

Table 96. Allergan Description and Business Overview

Table 97. Allergan Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 98. Allergan Opioid Induced Constipation (OIC) Drug Product

Table 99. Allergan Recent Developments/Updates

Table 100. Nektar Therapeutics Company Information

Table 101. Nektar Therapeutics Description and Business Overview

Table 102. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 103. Nektar Therapeutics Opioid Induced Constipation (OIC) Drug Product

Table 104. Nektar Therapeutics Recent Developments/Updates

Table 105. Purdue Pharma Company Information

Table 106. Purdue Pharma Description and Business Overview

Table 107. Purdue Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 108. Purdue Pharma Opioid Induced Constipation (OIC) Drug Product

Table 109. Purdue Pharma Recent Developments/Updates

Table 110. S.L.A. Pharma Company Information

Table 111. S.L.A. Pharma Description and Business Overview

Table 112. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 113. S.L.A. Pharma Opioid Induced Constipation (OIC) Drug Product

Table 114. S.L.A. Pharma Recent Developments/Updates

Table 115. Mundipharma International Limited Company Information

Table 116. Mundipharma International Limited Description and Business Overview

Table 117. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 118. Mundipharma International Limited Opioid Induced Constipation (OIC) Drug Product

Table 119. Mundipharma International Limited Recent Developments/Updates

Table 120. Ono Pharmaceutical Company Information

Table 121. Ono Pharmaceutical Description and Business Overview

Table 122. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 123. Ono Pharmaceutical Opioid Induced Constipation (OIC) Drug Product

Table 124. Ono Pharmaceutical Recent Developments/Updates

Table 125. Takeda Pharmaceutical Company Limited Company Information

Table 126. Takeda Pharmaceutical Company Limited Description and Business Overview

Table 127. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 128. Takeda Pharmaceutical Company Limited Opioid Induced Constipation (OIC) Drug Product

Table 129. Takeda Pharmaceutical Company Limited Recent Developments/Updates

Table 130. Theravance Biopharma Company Information

Table 131. Theravance Biopharma Description and Business Overview

Table 132. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 133. Theravance Biopharma Opioid Induced Constipation (OIC) Drug Product

Table 134. Theravance Biopharma Recent Developments/Updates

Table 135. Bausch Health Company Information

Table 136. Bausch Health Description and Business Overview

Table 137. Bausch Health Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 138. Bausch Health Opioid Induced Constipation (OIC) Drug Product

Table 139. Bausch Health Recent Developments/Updates

Table 140. Cosmo Pharmaceuticals SA Company Information

Table 141. Cosmo Pharmaceuticals SA Description and Business Overview

Table 142. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 143. Cosmo Pharmaceuticals SA Opioid Induced Constipation (OIC) Drug Product

Table 144. Cosmo Pharmaceuticals SA Recent Developments/Updates

Table 145. Daewoong Pharmaceutical Company Information

Table 146. Daewoong Pharmaceutical Description and Business Overview

Table 147. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 148. Daewoong Pharmaceutical Opioid Induced Constipation (OIC) Drug Product

Table 149. Daewoong Pharmaceutical Recent Developments/Updates

Table 150. C.B. Fleet Company Company Information

Table 151. C.B. Fleet Company Description and Business Overview

Table 152. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 153. C.B. Fleet Company Opioid Induced Constipation (OIC) Drug Product

Table 154. C.B. Fleet Company Recent Developments/Updates

Table 155. Sucampo Pharmaceuticals Company Information

Table 156. Sucampo Pharmaceuticals Description and Business Overview

Table 157. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)

Table 158. Sucampo Pharmaceuticals Opioid Induced Constipation (OIC) Drug Product

Table 159. Sucampo Pharmaceuticals Recent Developments/Updates

Table 160. Key Raw Materials Lists

Table 161. Raw Materials Key Suppliers Lists

Table 162. Opioid Induced Constipation (OIC) Drug Distributors List

Table 163. Opioid Induced Constipation (OIC) Drug Customers List

Table 164. Opioid Induced Constipation (OIC) Drug Market Trends

Table 165. Opioid Induced Constipation (OIC) Drug Market Drivers

Table 166. Opioid Induced Constipation (OIC) Drug Market Challenges

Table 167. Opioid Induced Constipation (OIC) Drug Market Restraints

Table 168. Research Programs/Design for This Report

Table 169. Key Data Information from Secondary Sources

Table 170. Key Data Information from Primary Sources

Table 171. Authors List of This Report

List of Figures

Figure 1. Product Picture of Opioid Induced Constipation (OIC) Drug

Figure 2. Global Opioid Induced Constipation (OIC) Drug Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Opioid Induced Constipation (OIC) Drug Market Share by Type: 2024 & 2031

Figure 4. Lubiprostone Product Picture

Figure 5. Methyl Naltrexone Bromide Product Picture

Figure 6. Naldemedine Product Picture

Figure 7. Alvimopan Product Picture

Figure 8. Other Product Picture

Figure 9. Global Opioid Induced Constipation (OIC) Drug Market Value by Distribution Channel (2020-2031) & (US$ Million)

Figure 10. Global Opioid Induced Constipation (OIC) Drug Market Share by Distribution Channel: 2024 & 2031

Figure 11. Hospital Pharmacies

Figure 12. Retail Pharmacies

Figure 13. Online Pharmacies

Figure 14. Global Opioid Induced Constipation (OIC) Drug Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Opioid Induced Constipation (OIC) Drug Market Size (2020-2031) & (US$ Million)

Figure 16. Global Opioid Induced Constipation (OIC) Drug Sales (2020-2031) & (K Units)

Figure 17. Global Opioid Induced Constipation (OIC) Drug Average Price (USD/Unit) & (2020-2031)

Figure 18. Opioid Induced Constipation (OIC) Drug Report Years Considered

Figure 19. Opioid Induced Constipation (OIC) Drug Sales Share by Manufacturers in 2024

Figure 20. Global Opioid Induced Constipation (OIC) Drug Revenue Share by Manufacturers in 2024

Figure 21. Global 5 and 10 Largest Opioid Induced Constipation (OIC) Drug Players: Market Share by Revenue in Opioid Induced Constipation (OIC) Drug in 2024

Figure 22. Opioid Induced Constipation (OIC) Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 23. Global Opioid Induced Constipation (OIC) Drug Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 24. North America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2020-2031)

Figure 25. North America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2020-2031)

Figure 26. U.S. Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 27. Canada Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. Europe Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2020-2031)

Figure 29. Europe Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2020-2031)

Figure 30. Germany Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. France Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. U.K. Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 33. Italy Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 34. Russia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Asia Pacific Opioid Induced Constipation (OIC) Drug Sales Market Share by Region (2020-2031)

Figure 36. Asia Pacific Opioid Induced Constipation (OIC) Drug Revenue Market Share by Region (2020-2031)

Figure 37. China Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Japan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. South Korea Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. India Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Australia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 42. Taiwan Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 43. Indonesia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Thailand Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Malaysia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Philippines Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 47. Latin America Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2020-2031)

Figure 48. Latin America Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2020-2031)

Figure 49. Mexico Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. Brazil Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Argentina Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 52. Middle East and Africa Opioid Induced Constipation (OIC) Drug Sales Market Share by Country (2020-2031)

Figure 53. Middle East and Africa Opioid Induced Constipation (OIC) Drug Revenue Market Share by Country (2020-2031)

Figure 54. Turkey Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 55. Saudi Arabia Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 56. U.A.E Opioid Induced Constipation (OIC) Drug Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 57. Global Sales Market Share of Opioid Induced Constipation (OIC) Drug by Type (2020-2031)

Figure 58. Global Revenue Market Share of Opioid Induced Constipation (OIC) Drug by Type (2020-2031)

Figure 59. Global Opioid Induced Constipation (OIC) Drug Price (USD/Unit) by Type (2020-2031)

Figure 60. Global Sales Market Share of Opioid Induced Constipation (OIC) Drug by Distribution Channel (2020-2031)

Figure 61. Global Revenue Market Share of Opioid Induced Constipation (OIC) Drug by Distribution Channel (2020-2031)

Figure 62. Global Opioid Induced Constipation (OIC) Drug Price (USD/Unit) by Distribution Channel (2020-2031)

Figure 63. Opioid Induced Constipation (OIC) Drug Value Chain

Figure 64. Channels of Distribution (Direct Vs Distribution)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions